Rheumnow

A Year in Review Dr. Jack Cush, Philadelphia Differences in Clinical Presentation and Outcomes of Early vs Late Onset PsA Dr. Olga Petryna, New York Abstract 0377 mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS Dr. Olga Petryna, New York Abstract 0004 Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor Dr. Sims discusses abstract 0199 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0199: Izokibep, a Novel IL-17A Inhibitor, Improves Patient-reported Outcomes – 16-Week Results from a Placebo-controlled Phase 2 Study in Patients with Active Psoriatic Arthritis The CONSUL Trial Dr. Sheila Reyes, The Phillipines Abstract 0526